Nine Monthly Results Results Snapshot
Figures in Cr
No Consolidated Results Declared by Sotac Pharma.
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Jun 2024 is -20.02% vs 0.59% in Jun 2024
Consolidate Net Profit
YoY Growth in nine months ended Jun 2024 is 16.07% vs 27.76% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Jun 2024 is -10.26% vs -11.04% in Jun 2024
Interest
YoY Growth in nine months ended Jun 2024 is 60.84% vs -24.74% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Jun 2024 has improved from Jun 2024
Compare Nine Monthly Results Of Sotac Pharma. With
Figures in Cr
No Consolidated Results Declared by Sotac Pharma.
Nine Monthly - Net Sales
Net Sales 62.26 Cr
in Jun 2024Figures in Cr
YoY Growth in nine months ended Jun 2024 is -20.02% vs 0.59% in Jun 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 3.90 Cr
in Jun 2024Figures in Cr
YoY Growth in nine months ended Jun 2024 is 16.07% vs 27.76% in Jun 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.86 Cr
in Jun 2024Figures in Cr
YoY Growth in nine months ended Jun 2024 is -10.26% vs -11.04% in Jun 2024
Nine Monthly - Interest
Interest 2.30 Cr
in Jun 2024Figures in Cr
YoY Growth in nine months ended Jun 2024 is 60.84% vs -24.74% in Jun 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.41%
in Jun 2024Figures in %
YoY Growth in nine months ended Jun 2024 has improved from Jun 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
